
Bath & body works lowers outlook, citing consumer caution during high inflation
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

The entrance to a Bath & Body Works store. Jeff Greenberg | Getty Images Shares of Bath & Body Works initially fell Wednesday after the company lowered its sales and earnings
outlook, citing a more challenging macroeconomic environment. But the stock clawed its way into positive territory later in the day, closing up 3% at $31.10. "Our data indicates that
customers, particularly lower income customers, have become more cost conscious and are limiting purchases," the company said in a statement. For the second quarter, the home fragrance
and personal care retailer said it now expects sales to be down 6% to 7% from the same time last year. For the full year, it now expects sales to be down mid- to high-single digits from
2021. Previously, Bath & Body had forecast second-quarter and full-year sales to grow in the low single digits from a year ago. Bath & Body Works also said it now expect
second-quarter earnings from continuing operations to be 40 to 42 cents per share, down from its previous forecast of 60 to 65 cents a share. The company said it sought to address the more
cautious spending by increasing sales and promotions, but noted that the moves have impacted its margins. Bath & Body Works is scheduled to report its second-quarter earnings on August
17. Analysts at Raymond James said Wednesday they were remaining bullish on the stock. "We continue to rate shares Strong Buy as we believe they already reflect the impact of a more
significant slowdown, while the company's solid innovation pipeline and initiatives such as the loyalty program, as well as margin pressure alleviating, position the company well for
medium- to long-term growth," they wrote.